Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
LMND
|
Daniel A. Schreiber
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 56,650 Reduced 7.32% |
$3,766,092
$66.48 p/Share
|
Dec 01
2020 |
LMND
|
Timothy E Bixby
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,100 Reduced 6.28% |
$1,337,253
$66.53 p/Share
|
Dec 01
2020 |
LMND
|
John Sheldon Peters
Chief Insurance Officer |
SELL
Open market or private sale
|
Direct | 28,800 Reduced 19.65% |
$1,914,624
$66.48 p/Share
|
Dec 01
2020 |
PLAB
|
Christopher J Progler
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 8,340 Reduced 6.83% |
$98,245
$11.78 p/Share
|
Dec 01
2020 |
TNC
|
Chris Killingstad
Director |
SELL
Open market or private sale
|
Direct | 6,592 Reduced 4.22% |
$446,806
$67.78 p/Share
|
Dec 01
2020 |
ARQT
|
Howard G. Welgus
Director |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 1.21% |
$57,816
$26.28 p/Share
|
Dec 01
2020 |
SSP
|
Mark L Koors
VP/Audit and Compliance |
SELL
Open market or private sale
|
Direct | 11,452 Reduced 22.78% |
$148,876
$13.0 p/Share
|
Dec 01
2020 |
SNDX
|
Michael A Metzger
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 45.93% |
$344,550
$22.97 p/Share
|
Dec 01
2020 |
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.62% |
$124,960
$31.24 p/Share
|
Dec 01
2020 |
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 51.2% |
$124,960
$31.24 p/Share
|
Dec 01
2020 |
HCAT
|
Paul Horstmeier
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,750 Reduced 11.68% |
$380,765
$35.42 p/Share
|
Dec 01
2020 |
HCAT
|
James Patrick Nelli Jr.
President |
SELL
Open market or private sale
|
Direct | 33,582 Reduced 27.79% |
$1,188,803
$35.4 p/Share
|
Dec 01
2020 |
HCAT
|
Daniel D. Burton
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,482 Reduced 2.12% |
$156,780
$34.98 p/Share
|
Dec 01
2020 |
HCAT
|
Daniel H. Orenstein
General Counsel |
SELL
Open market or private sale
|
Direct | 6,084 Reduced 15.21% |
$212,757
$34.97 p/Share
|
Dec 01
2020 |
HCAT
|
Linda Llewelyn
Chief People Officer |
SELL
Open market or private sale
|
Direct | 1,570 Reduced 6.19% |
$54,934
$34.99 p/Share
|
Dec 01
2020 |
DCPH
|
Michael Douglas Taylor
Director |
SELL
Open market or private sale
|
Direct | 19,000 Reduced 100.0% |
$1,169,450
$61.55 p/Share
|
Dec 01
2020 |
ATEX
|
Elaine Gangeri
Chief Acc Officer, Treasurer |
SELL
Open market or private sale
|
Direct | 1,018 Reduced 3.6% |
$30,642
$30.1 p/Share
|
Dec 01
2020 |
QTRX
|
Mark T. Roskey
SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct | 91 Reduced 0.41% |
$3,979
$43.72 p/Share
|
Dec 01
2020 |
QTRX
|
Dawn Mattoon
Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct | 158 Reduced 0.5% |
$6,908
$43.72 p/Share
|
Dec 01
2020 |
QTRX
|
Amol Chaubal
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 115 Reduced 0.45% |
$5,028
$43.72 p/Share
|
Dec 01
2020 |
QTRX
|
John J Fry
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 141 Reduced 0.44% |
$6,165
$43.72 p/Share
|
Dec 01
2020 |
QTRX
|
E Kevin Hrusovsky
Executive Chairman |
SELL
Open market or private sale
|
Direct | 3,236 Reduced 0.32% |
$141,478
$43.72 p/Share
|
Dec 01
2020 |
BLFS
|
Aby J. Mathew
EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 380 Reduced 0.21% |
$13,486
$35.49 p/Share
|
Dec 01
2020 |
BLFS
|
Karen A. Foster
Chief Quality and Operations |
SELL
Open market or private sale
|
Direct | 166 Reduced 0.33% |
$5,891
$35.49 p/Share
|
Dec 01
2020 |
BLFS
|
Michael Rice |
SELL
Open market or private sale
|
Direct | 813 Reduced 0.4% |
$28,853
$35.49 p/Share
|
Dec 01
2020 |
CSTL
|
Bernhard E. Spiess
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 77.3% |
$1,998,800
$49.97 p/Share
|
Dec 01
2020 |
QNST
|
Douglas Valenti
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,083 Reduced 0.53% |
$37,702
$18.1 p/Share
|
Dec 01
2020 |
BCYC
|
Lee Kalowski
President and CFO |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 100.0% |
$168,750
$22.5 p/Share
|
Dec 01
2020 |
MBWM
|
Robert T. Worthington
SVP, CRO, SECRETARY, AND GC |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 28.35% |
$87,640
$25.04 p/Share
|
Dec 01
2020 |
STOK
|
Huw M. Nash
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 5,700 Reduced 100.0% |
$289,845
$50.85 p/Share
|
Dec 01
2020 |
TPIC
|
Daniel G Weiss |
SELL
Open market or private sale
|
Indirect | 61,376 Reduced 26.59% |
$2,626,893
$42.8 p/Share
|
Dec 01
2020 |
ARCT
|
Pad Chivukula
Chief Scientific Officer & COO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.42% |
$961,900
$96.19 p/Share
|
Dec 01
2020 |
AMRK
|
Thor Gjerdrum
President |
SELL
Open market or private sale
|
Direct | 19,169 Reduced 100.0% |
$583,313
$30.43 p/Share
|
Dec 01
2020 |
CVEO
|
Bradley J Dodson
President & CEO |
SELL
Open market or private sale
|
Direct | 8,333 Reduced 5.57% |
$129,661
$15.56 p/Share
|
Dec 01
2020 |
KPTI
|
Christopher Brett Primiano
EVP, CBO, GC & Secretary |
SELL
Open market or private sale
|
Direct | 137,061 Reduced 96.81% |
$2,399,938
$17.51 p/Share
|
Dec 01
2020 |
AMOT
|
Richard S Warzala
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 0.25% |
$102,425
$40.97 p/Share
|
Dec 01
2020 |
MCRB
|
Matthew R. Henn |
SELL
Open market or private sale
|
Direct | 91,812 Reduced 100.0% |
$2,523,912
$27.49 p/Share
|
Dec 01
2020 |
PHAT
|
Azmi Nabulsi
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 7,198 Reduced 0.42% |
$319,663
$44.41 p/Share
|
Dec 01
2020 |
ZYME
|
Diana Hausman
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 18,267 Reduced 83.09% |
$1,008,156
$55.19 p/Share
|
Dec 01
2020 |
CURO
|
William C Baker
President & COO |
SELL
Open market or private sale
|
Direct | 47,660 Reduced 12.07% |
$403,680
$8.47 p/Share
|
Dec 01
2020 |
GTHX
|
Seth Rudnick |
SELL
Open market or private sale
|
Indirect | 520 Reduced 0.89% |
$10,447
$20.09 p/Share
|
Dec 01
2020 |
ATOM
|
Erwin Trautmann
Director |
SELL
Open market or private sale
|
Direct | 456 Reduced 0.46% |
$4,332
$9.5 p/Share
|
Dec 01
2020 |
ATOM
|
Robert J Mears
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 2,285 Reduced 1.58% |
$21,708
$9.5 p/Share
|
Dec 01
2020 |
ATOM
|
Francis Laurencio
CFO |
SELL
Open market or private sale
|
Direct | 2,708 Reduced 3.7% |
$25,726
$9.5 p/Share
|
Dec 01
2020 |
ATOM
|
Scott A. Bibaud
CEO and President |
SELL
Open market or private sale
|
Direct | 6,782 Reduced 2.35% |
$64,429
$9.5 p/Share
|
Dec 01
2020 |
NDLS
|
Catterton Noodles Holdings, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,000,000 Reduced 35.87% |
$7,500,000
$7.5 p/Share
|
Dec 01
2020 |
PSNL
|
Richard Chen
CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 26.19% |
$1,118,000
$27.95 p/Share
|
Dec 01
2020 |
VRA
|
Patricia R. Miller
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 245,824 Reduced 9.83% |
$1,969,050
$8.01 p/Share
|
Dec 01
2020 |
VRA
|
P. Michael Miller
Director |
SELL
Open market or private sale
|
Indirect | 245,824 Reduced 9.83% |
$1,969,050
$8.01 p/Share
|
Dec 01
2020 |
OBCI
|
Gregor M Dornau
EVP Sales & Marketing |
SELL
Open market or private sale
|
Direct | 750 Reduced 0.16% |
$10,073
$13.43 p/Share
|
Dec 01
2020 |